Search
Travere Therapeutics Inc
TVTXAdd to Watchlist
55.150USD
+1.010+1.87%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.01BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
FILSPARI
322.00M
78.45%
Tiopronin Products
88.45M
21.55%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
FILSPARI
322.00M
78.45%
Tiopronin Products
88.45M
21.55%
